NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells.
Bruno Ricardo Barreto PiresAndre L MencalhaGerson M FerreiraWaldemir F de SouzaJosé A Morgado-DíazAmanda M MaiaStephany CorrêaEliana S F W AbdelhayPublished in: PloS one (2017)
The metastatic process in breast cancer is related to the expression of the epithelial-to-mesenchymal transition transcription factors (EMT-TFs) SNAIL, SLUG, SIP1 and TWIST1. EMT-TFs and nuclear factor-κB (NF-κB) activation have been associated with aggressiveness and metastatic potential in carcinomas. Here, we sought to examine the role of NF-κB in the aggressive properties and regulation of EMT-TFs in human breast cancer cells. Blocking NF-κB/p65 activity by reducing its transcript and protein levels (through siRNA-strategy and dehydroxymethylepoxyquinomicin [DHMEQ] treatment) in the aggressive MDA-MB-231 and HCC-1954 cell lines resulted in decreased invasiveness and migration, a downregulation of SLUG, SIP1, TWIST1, MMP11 and N-cadherin transcripts and an upregulation of E-cadherin transcripts. No significant changes were observed in the less aggressive cell line MCF-7. Bioinformatics tools identified several NF-κB binding sites along the promoters of SNAIL, SLUG, SIP1 and TWIST1 genes. Through chromatin immunoprecipitation and luciferase reporter assays, the NF-κB/p65 binding on TWIST1, SLUG and SIP1 promoter regions was confirmed. Thus, we suggest that NF-κB directly regulates the transcription of EMT-TF genes in breast cancer. Our findings may contribute to a greater understanding of the metastatic process of this neoplasia and highlight NF-κB as a potential target for breast cancer treatment.
Keyphrases
- epithelial mesenchymal transition
- signaling pathway
- nuclear factor
- pi k akt
- breast cancer cells
- lps induced
- transcription factor
- squamous cell carcinoma
- genome wide
- toll like receptor
- oxidative stress
- small cell lung cancer
- poor prognosis
- dna methylation
- endothelial cells
- dna damage
- cell death
- cell proliferation
- immune response
- crispr cas
- climate change
- high throughput
- drug delivery
- cell migration
- amino acid
- binding protein
- rna seq
- smoking cessation